RT @dronita_de: Future cancer research priorities in the USA: a Lancet Oncology Commission https://t.co/KBpCuBTTL4 #DHPSP
Future cancer research priorities in the USA: a Lancet Oncology Commission https://t.co/KBpCuBTTL4 #DHPSP
RT @atulbutte: @moorejh Don’t forget our work from 2017! 😜 Future cancer research priorities in the USA: a Lancet Oncology Commission https…
@moorejh Don’t forget our work from 2017! 😜 Future cancer research priorities in the USA: a Lancet Oncology Commission https://t.co/UoYVDbYugR
RT @TheLancetOncol: At #AACR19? Visit @TheLancet booth #3128 & pick up copies of our February https://t.co/aBNghsVz48 & March issues https:…
RT @TheLancetOncol: At #AACR19? Visit @TheLancet booth #3128 & pick up copies of our February https://t.co/aBNghsVz48 & March issues https:…
At #AACR19? Visit @TheLancet booth #3128 & pick up copies of our February https://t.co/aBNghsVz48 & March issues https://t.co/8mSZEfI8iF & our #FutureCancerUSA Commission https://t.co/j37Ww8mCP0 Editor-in-Chief, David Collingridge, will be the
RT @TheLancetOncol: At #AACR19? Visit @TheLancet booth #3128 & pick up copies of our February https://t.co/7QwmesgMOb & March issues https:…
At #AACR19? Visit @TheLancet booth #3128 & pick up copies of our February https://t.co/7QwmesgMOb & March issues https://t.co/stiVdfsDJ5 & our #FutureCancerUSA Commission https://t.co/KjRFSYD0mH Editor-in-Chief, David Collingridge, will be the
RT @ISR_Radiology: Read ISR's note on Precision Oncology by @TheLancet here: https://t.co/OfnPOeTjSi … or click to download the full report…
Read ISR's note on Precision Oncology by @TheLancet here: https://t.co/OfnPOeTjSi … or click to download the full report: https://t.co/5f70USGPXl #Radiology #Imaging #Oncology #LancetOncology https://t.co/clOQZ3vxSU
RT @TheLancetOncol: On #InternationalChildhoodCancerDay, read about priorities for #childhoodcancer in The Lancet Oncology Commission: Futu…
At #ASH18? Meet & ask your questions to our Senior Editor and pick up free copies of our Oct https://t.co/OjuWHoU3H4 and Nov issues https://t.co/Wu9ns5uNLZ and our #FutureCancerUSA Commission https://t.co/w6JLjBprZ3 at The Lancet booth https://t.co/u6Y
RT @TheLancetOncol: At #ASH18? Meet & ask your questions to our Senior Editor and pick up free copies of our Oct https://t.co/OjuWHoU3H4 an…
RT @TheLancetOncol: At #ASH18? Meet & ask your questions to our Senior Editor and pick up free copies of our Oct https://t.co/OjuWHoU3H4 an…
At #ASH18? Meet & ask your questions to our Senior Editor and pick up free copies of our Oct https://t.co/OjuWHoU3H4 and Nov issues https://t.co/Wu9ns5uNLZ and our #FutureCancerUSA Commission https://t.co/w6JLjBprZ3 at The Lancet booth https://t.co/6o
As #IPOS18 attendees the challenge is to ensure more equitable research investment, funding to tackle the hard questions not just more 'same same' interventions https://t.co/v8ImKCZQe9 @nicole_rankin8n
RT @debby_keller: Future cancer research priorities in the USA: a Lancet Oncology Commission @TheLancetOncol @TheLancet #surgicalresearch @…
RT @debby_keller: Future cancer research priorities in the USA: a Lancet Oncology Commission @TheLancetOncol @TheLancet #surgicalresearch @…
RT @debby_keller: Future cancer research priorities in the USA: a Lancet Oncology Commission @TheLancetOncol @TheLancet #surgicalresearch @…
RT @debby_keller: Future cancer research priorities in the USA: a Lancet Oncology Commission @TheLancetOncol @TheLancet #surgicalresearch @…
Future cancer research priorities in the USA: a Lancet Oncology Commission @TheLancetOncol @TheLancet #surgicalresearch @McMastersKelly @AACRPres @sandralwong https://t.co/y7lFDzmfXl
RT @TheLancetOncol: At #ASCO2018 @ASCO? Visit Elsevier booth 21096 and pick up free copies our May https://t.co/05hc0AE5Ft and June issues…
RT @TheLancetOncol: The Lancet Oncology Commission highlights 13 key priority #cancer research areas to achieve Moonshot in the USA #Future…
RT @TheLancetOncol: At #ASCO2018 @ASCO? Come and visit Elsevier booth 21096 to pick up free copies our May https://t.co/05hc0AE5Ft and June…
RT @TheLancetOncol: At #ASCO2018 @ASCO? Have you visited Elsevier booth 21096 yet? Free copies are available of our May https://t.co/05hc0A…
RT @hccconnectinfo: Additional cancer research priority areas in the U.S. #HCCConnect https://t.co/I5BLQFEJl1
RT @TheLancetOncol: At #ASCO2018 @ASCO? Have you visited Elsevier booth 21096 yet? Free copies are available of our May https://t.co/05hc0A…
RT @TheLancetOncol: At #ASCO2018 @ASCO? Have you visited Elsevier booth 21096 yet? Free copies are available of our May https://t.co/05hc0A…
At #ASCO2018 @ASCO? Have you visited Elsevier booth 21096 yet? Free copies are available of our May https://t.co/05hc0AE5Ft and June issues https://t.co/DqoWwFlyLv and our #FutureCancerUSA Commission https://t.co/wggITzSm09 https://t.co/2hUqKhR3wQ
RT @TheLancetOncol: At #ASCO2018 @ASCO? Come and visit Elsevier booth 21096 to pick up free copies our May https://t.co/05hc0AE5Ft and June…
RT @TheLancetOncol: At #ASCO2018 @ASCO? Come and visit Elsevier booth 21096 to pick up free copies our May https://t.co/05hc0AE5Ft and June…
RT @TheLancetOncol: The Lancet Oncology Commission highlights 13 key priority #cancer research areas to achieve Moonshot in the USA #Future…
RT @TheLancetOncol: At #ASCO2018 @ASCO? Come and visit Elsevier booth 21096 to pick up free copies our May https://t.co/05hc0AE5Ft and June…
At #ASCO2018 @ASCO? Come and visit Elsevier booth 21096 to pick up free copies our May https://t.co/05hc0AE5Ft and June issues https://t.co/DqoWwFlyLv and our #FutureCancerUSA Commission https://t.co/wggITzSm09
RT @TheLancetOncol: The Lancet Oncology Commission highlights 13 key priority #cancer research areas to achieve Moonshot in the USA #Future…
Additional cancer research priority areas in the U.S. #HCCConnect https://t.co/I5BLQFEJl1
RT @TheLancetOncol: The Lancet Oncology Commission highlights 13 key priority #cancer research areas to achieve Moonshot in the USA #Future…
RT @TheLancetOncol: The Lancet Oncology Commission highlights 13 key priority #cancer research areas to achieve Moonshot in the USA #Future…
RT @TheLancetOncol: The Lancet Oncology Commission highlights 13 key priority #cancer research areas to achieve Moonshot in the USA #Future…
RT @TheLancetOncol: The Lancet Oncology Commission highlights 13 key priority #cancer research areas to achieve Moonshot in the USA #Future…
The Lancet Oncology Commission highlights 13 key priority #cancer research areas to achieve Moonshot in the USA #FutureCancerUSA https://t.co/wggITzSm09 Free copies available at #ASCO2018 @ASCO, Elsevier booth 21096
At #ASCO2018 @ASCO? Visit Elsevier booth 21096 and pick up free copies our May https://t.co/05hc0AE5Ft and June issues https://t.co/DqoWwFlyLv and our #FutureCancerUSA Commission https://t.co/wggITzSm09
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
Interesting paper on future of meaningful #cancer #research https://t.co/XLPVTl2X45 https://t.co/YueZ2nvmHP
RT @TheLancetOncol: We’re at #AACR18 at @TheLancet booth 3331. Collect your free journal copies including the March and April issues and th…
RT @TheLancetOncol: We’re at #AACR18 at @TheLancet booth 3331. Collect your free journal copies including the March and April issues and th…
RT @TheLancetOncol: On #InternationalChildhoodCancerDay, read about priorities for #childhoodcancer in The Lancet Oncology Commission: Futu…
RT @TheLancetOncol: On #InternationalChildhoodCancerDay, read about priorities for #childhoodcancer in The Lancet Oncology Commission: Futu…
RT @TheLancetOncol: On #InternationalChildhoodCancerDay, read about priorities for #childhoodcancer in The Lancet Oncology Commission: Futu…
RT @TheLancetOncol: On #InternationalChildhoodCancerDay, read about priorities for #childhoodcancer in The Lancet Oncology Commission: Futu…
On #InternationalChildhoodCancerDay, read about priorities for #childhoodcancer in The Lancet Oncology Commission: Future #CancerResearch Priorities in the #USA https://t.co/xC5zDkXr1u #Together4kidswcancer https://t.co/Pg41XaKtbv
Another of my favorite papers of 2017: Future cancer research priorities in the USA. Roadmap for cancer research: develop a premalignant cancer atlas, harness big data to identify high risk populations, reduce unnecessary imaging and testing https://t.co/Q
Future cancer research priorities in the USA: a Lancet Oncology Commission. https://t.co/QKjFNdr1k5
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @SocEspPR: Future cancer research priorities in the USA https://t.co/4lkubfvD1F
RT @SocEspPR: Future cancer research priorities in the USA https://t.co/4lkubfvD1F
Future cancer research priorities in the USA https://t.co/4lkubfvD1F
RT @drbachinsky: Future cancer research priorities in the USA: a Lancet Oncology Commission https://t.co/JSsoQLw6PQ
Future #cancer research priorities in the USA https://t.co/iOmhjMFKyg
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
Nice to see a section on childhood cancer survivorship in the new @TheLancetOncol future cancer research priorities https://t.co/4vgSp8HFqy
Key report on future cancer research priorities from the Lancet Oncology @TheLancetOncol https://t.co/4FoH20SCq0
每年美國有二百五十名醫護人員加入紓緩醫學的受訓(應該指專科的紓緩醫學),雖然估計合共需要六千至一萬紓緩醫學的專科醫生才能應付全國住院病人的需要。... https://t.co/fmWRGBJW17
Future cancer research priorities in the USA: a Lancet Oncology Commission https://t.co/XIfCN78Atw
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @FabienReyal: Acces 2 expert cancer surgeons a cornerstone of cancer treatment @TheLancetOncol https://t.co/pLUbdDJMfU @institut_curie @…
Acces 2 expert cancer surgeons a cornerstone of cancer treatment @TheLancetOncol https://t.co/pLUbdDJMfU @institut_curie @Institut_cancer https://t.co/VnhgdSyxnX
RT @richardhorton1: What is the future for cancer care + research? Here is the view of a specially convened Lancet Oncology Commission. htt…
Here is the link to the report https://t.co/dzbK7izCWB https://t.co/4DPy4PjCnt
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
Future cancer research priorities in the USA: a @TheLancetOncol Commission https://t.co/yLB20R3HgB https://t.co/QVMKQ1Bwdo
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @richardhorton1: What is the future for cancer care + research? Here is the view of a specially convened Lancet Oncology Commission. htt…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…
RT @maxinesun: @DanaFarber leads in US cancer research w/ an impressive field-weighted citation impact (FWCI) of 4.62 in 2011-15. https://t…
Definitely want to read this! https://t.co/VYS2oB1Xsn
RT @EricTopol: If you're interested where the field of #cancer is headed, this 54-page #OA @TheLancetOnco paper is rich, >400 refs https://…